guaiacol has been researched along with transforming growth factor beta in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SG; Kim, YC; Ma, CJ; Park, EY; Shin, SM | 1 |
| Chen, CY; Chiu, CC; Chou, YT; Wang, HM; Wu, CP | 1 |
| Bae, JS; Ku, SK; Lee, T; Min, G | 1 |
3 other study(ies) available for guaiacol and transforming growth factor beta
| Article | Year |
|---|---|
meso-dihydroguaiaretic acid from Machilus thunbergii down-regulates TGF-beta1 gene expression in activated hepatic stellate cells via inhibition of AP-1 activity.
Topics: Animals; DNA Primers; Dose-Response Relationship, Drug; Down-Regulation; Guaiacol; Immunoblotting; Immunohistochemistry; Lauraceae; Lignans; Liver; Male; Phytotherapy; Plant Bark; Plant Extracts; Protective Agents; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Enhancements of skin cell proliferations and migrations via 6-dehydrogingerdione.
Topics: Cell Movement; Cell Proliferation; Fatty Alcohols; Fibroblasts; Guaiacol; Humans; Plant Extracts; Platelet-Derived Growth Factor; Skin; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Zingiber officinale | 2013 |
Suppressive effects of zingerone on TGFBIp-mediated septic responses.
Topics: Animals; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Guaiacol; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred C57BL; Sepsis; Transforming Growth Factor beta; Treatment Outcome | 2018 |